Phase-3 trial of Oxford-AstraZeneca Covid-19 vaccine to begin in few days

AstraZeneca Plc has resumed the U.S. trial of its experimental COVID-19 vaccine after approval by regulators, and Johnson & Johnson is preparing to resume its trial on Monday or Tuesday, the companies said on Friday.